Genentech’s Rituxan approved for rare skin diseaseThe FDA has approved Genentech’s Rituxan (rituximab) for use in adults with moderate-to-severe pemphigus vulgaris (PV), making it the first treatment for the condition in more than 60 years. Share XGenentech’s Rituxan approved for rare skin diseasehttps://pharmaphorum.com/news/genentechs-rituxan-rare-skin-disease/